Atlas Trials

Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects

Clinical trial NCT02972905 · COMPLETED

Trial details

NCT number
NCT02972905
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2016-10-01
Primary completion
2016-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.